Soley Therapeutics
PrivateLast Round
Series C
Jan 7, 2026
Total Funding Raised
$290M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Soley Therapeutics operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series C round in January 2026.
Soley Therapeutics is a biotechnology company that uses its proprietary cell stress-sensing platform, integrated with AI and automation, to discover and develop first-in-class medicines for oncology, neurodegenerative, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Soley Therapeutics Comparables
Compare Soley Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Relay Therapeutics | 72% | |
| Eikon | 70% | |
| MicroQuin | 65% |
For institutional investors. Book with your work email.
Soley Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 7, 2026 | ||||
| Series A | Dec 22, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Soley Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series C |
| Breyer Capital | Series B, Series C, Series A |
| GordonMD Global Investments | Series B, Series C, Series A |
| HRTG Partners | Series C |
| RWN Management | Series C |
| Citadel | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 36% MoM.
- Aug 20, 2026
Monthly visitors increased 55% MoM.
For institutional investors. Book with your work email.
Soley Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Soley Therapeutics's valuation, stock price, and market status.
Is Soley Therapeutics a public or private company?
Soley Therapeutics is a private company.
What is the current stock price of Soley Therapeutics?
Soley Therapeutics is a private company, so its shares have no public market price. Caplight tracks Soley Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Soley Therapeutics worth (valuation)?
Valuation information for Soley Therapeutics is not publicly available.
Can I buy Soley Therapeutics stock?
Soley Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Soley Therapeutics's last funding round?
Soley Therapeutics's most recent funding round was Series C on January 7, 2026.
Who are the main investors in Soley Therapeutics?
Key investors in Soley Therapeutics include Surveyor Capital, Citadel.
Will Soley Therapeutics IPO soon?
No public IPO plans have been announced for Soley Therapeutics.
How can I track Soley Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Soley Therapeutics's shares on secondary markets.